Cancer is a disease arising from abnormalities in cell function, characterized by uncontrolled cell growth and the potential to invade other parts of the body.
It's a disease where abnormal tissues grow and spread unrestrained throughout the body, disrupting normal tissue function and potentially leading to organ failure.
Almost half of the UK population will eventually develop cancer, making it the second leading cause of death, highlighting the importance of early detection and treatment.
Understanding cancer biology requires detailed knowledge of normal cell behavior, including cell signaling, DNA replication, and programmed cell death (apoptosis).
Cancers are grouped into different categories depending on the cell type involved:
Carcinoma: Arises from epithelial cells that cover external and internal surfaces; these are the most common types of cancer.
Examples: Lung, Breast, Colon. These often spread through lymphatic vessels.
Sarcoma: Arises from cells of supporting tissues, which are less common than carcinomas.
Examples: Bone (osteosarcoma), Cartilage (chondrosarcoma), Fat (liposarcoma), Connective tissue, Muscle (rhabdomyosarcoma).
Leukaemia & Lymphoma: Arise from blood and lymphatic cells, affecting the body's ability to fight infection.
Examples: Blood (acute myeloid leukemia), Bone marrow, Lymph nodes (Hodgkin's lymphoma), and other lymphoid organs
Tumor formation involves:
Uncontrolled proliferation, where cells divide excessively without proper regulation.
Disrupted balance between cell division and cell differentiation, leading to an accumulation of immature cells.
Normal Growth: Balanced proliferation and differentiation, maintaining tissue homeostasis.
Example: Skin
Outer skin surface with shedding of dead cells.
Squamous cells.
Cell migration from the basal layer (dividing cells).
Basal lamina.
Underlying tissue.
Tumor Growth: Imbalanced proliferation and differentiation, resulting in tumor mass.
Example: Skin - Carcinoma
Underlying tissue involvement, indicating invasive growth.
Genetic mutations cause abnormalities in cell function observed in cancer cells, disrupting normal cellular processes.
Mutations in genes controlling cell proliferation and division contribute to cancer development; these genes are critical for maintaining genomic stability.
Two main gene classes are affected:
Oncogenes, which promote cell growth and division when activated.
Tumour suppressor genes, which inhibit cell growth and division, preventing tumor formation.
Proto-oncogenes regulate cell growth, proliferation, and gene expression; they are essential for normal cell function.
Mutation in a proto-oncogene can result in an oncogene, leading to uncontrolled cell growth.
Oncogenes drive unrestrained cell proliferation and confer malignant characteristics to cells, contributing to cancer development.
Gain of function mutation, where the gene product has increased activity or new functions.
Example: RAS gene, which is involved in cell signaling pathways.
(a) Point mutation: Single nucleotide substitution causing a single amino acid substitution in the protein encoded by the normal proto-oncogene, altering its function.
Example: RAS oncogene codes for an abnormal form of Ras protein that drives progression through the S phase of the cell cycle.
Associated cancers: Bladder, Colon, Lung, Pancreas, Thyroid.
(b) Gene amplification: Increased number of copies of a proto-oncogene; the protein encoded is produced in excessive amounts, although the protein is normal, leading to increased cell signaling.
Example: ERBB2 gene codes for a growth factor receptor.
Associated cancers: Breast, Ovarian. This amplification leads to excessive cell proliferation.
(c) Chromosomal translocations: Part of one chromosome is removed and joined to another chromosome, disrupting normal gene regulation.
Example: Proto-oncogene MYC is translocated from chromosome 8 to 14 and overexpressed. The MYC gene encodes a transcription factor that stimulates cell proliferation.
Associated cancer: Burkitt’s lymphoma. The translocation causes the MYC gene to be under the control of a highly active promoter.
(d) Local DNA rearrangements: Insertions, deletions, inversions, or transpositions of proto-oncogenes, altering their expression or function.
Example: TRK oncogene encodes a fusion protein that encodes a hyperactivated tyrosine kinase.
Associated cancers: Thyroid, Colon. These rearrangements can lead to constitutive activation of the kinase.
(e) Insertional mutagenesis: Retrovirus-induced - viral DNA inserted into a proto-oncogene, activating its expression.
Rare event but significant in understanding oncogenesis.
Tumour suppressor genes regulate the cell cycle, DNA repair, and cell death, preventing uncontrolled cell growth.
Mutation in a tumour suppressor gene can disrupt its function, leading to loss of growth control.
Loss of function mutation, where the gene product is inactivated or absent.
Example: TP53 gene - half of all human cancers have p53 loss of function mutation, making it a critical target for cancer therapy.
Most commonly mutated gene in human cancers.
p53 responds to various cellular stresses:
Lack of nucleotides, UV radiation, ionizing radiation, oncogene signaling, hypoxia, blockage of transcription.
p53 blocks the replication of damaged or mutated cells, preventing the propagation of genetic errors.
It can trigger:
Cell cycle arrest, providing time for DNA repair.
DNA repair, fixing damaged DNA to restore normal function.
Block of angiogenesis, preventing the formation of new blood vessels that feed tumors.
Apoptosis, inducing programmed cell death to eliminate damaged cells.
Senescence, causing cells to enter a state of permanent growth arrest.
If these processes are successful, the cell can return to proliferation. Otherwise, the cell undergoes